Norfloxacin, pentoxifylline, inhaled N(G)-nitro-L-arginine methyl ester, nitric oxide inhalation and methylene blue injection, are among suggested and studied medical treatments for HPS. Most of them failed to show efficacy and hence, non of them yet approved as a standard treatment for HPS.
Hepatopulmonary syndrome future or investigational therapies
Acute liver failure future or investigational therapies
Drug induced liver injury medical therapy
Hepatic encephalopathy primary prevention
Hepatopulmonary syndrome secondary prevention
Cirrhosis future or investigational therapies
Hepatic encephalopathy secondary prevention
Alcoholic hepatitis secondary prevention